> Sanofi ($SNY) invested $700 million in Alnylam's ($ALNY) RNAi technology. Story
> Merck ($MRK) sold Sirna Therapeutics, its RNAi arm, to Alnylam ($ALNY). Article
> Researchers at the University of North Carolina have come up with a new way to visualize RNA, an advancement that could have future implications for drug delivery. More
> Interface Biologics and Q3 Medical Devices signed an agreement to develop a drug-coated balloon with Interface's Kinesyx technology. Release